Stryker stock: October 29 results are next for Stryker stock

Published on 10/22/2026 at 17:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal 2026 earnings per share guidance is USD 14.95-15.10. Stryker stock costs EUR 272.45 on October 22, 2026, up 2.58 percent versus Xetra close.

Results and valuation

Stryker scheduled its third-quarter results for October 29, 2026.
Fiscal 2026 earnings per share guidance stands at USD 14.95-15.10.
Stryker stock costs EUR 272.45 at Lang & Schwarz on October 22, 2026 at 5:04 p.m. CEST, 2.58 percent above the Xetra close of October 21, 2026.

Makrofoto einer polierten Titan-Implantatoberfläche mit feiner Textur und Lichtreflexen — Makroaufnahme einer Titan-Implantatoberfläche zeigt Präzisionsfertigung, typisch für Produkte von Stryker Corp. US8636671013, Illustration mit AI erstellt.

Stryker Corporation (ISIN US8636671013) has scheduled its third-quarter results for October 29, 2026, according to the company's investor-relations calendar from Stryker. At 5:04 p.m. CEST on October 22, 2026, the stock was trading at EUR 272.45 at Lang & Schwarz, 2.58 percent above the Xetra close of October 21, 2026 at EUR 265.60.

Guidance sets the earnings frame

Stryker's fiscal 2026 earnings per share guidance stands at USD 14.95-15.10. MarketBeat reported the range on October 12, 2026, alongside the company's latest quarterly figures. The October 29 report will test that outlook against the next operating update.

Stock stays below its yearly high

The primary-market quote was USD 305.79 at 3:10 p.m. UTC on October 22, 2026, equivalent to 11:10 a.m. ET, while the session range was USD 299.36 to USD 306.20. The 52-week range was USD 267.00 to USD 389.33, placing the stock 21.46 percent below its high. Volume stood at 466,340 shares at the same timestamp.

Valuation and reporting date

MarketBeat identifies Stryker as NYSE: SYK and reported a price-to-earnings ratio of 28.73 and market capitalization of USD 106.35 billion on October 12, 2026. The structured market quote placed the market capitalization at USD 117.3 billion on October 22, 2026, with a price-to-earnings ratio of 31.69. The differing snapshots reflect their separate dates.

Comparison with peers

Stryker Corporation: up 2.58 percent versus the Xetra close, price-to-earnings ratio 31.69, market capitalization USD 117.3 billion. Medtronic (NYSE, USD): up 2.83 percent, price-to-earnings ratio 23.50, market capitalization USD 122.4 billion. Boston Scientific (NYSE, USD): up 1.93 percent, price-to-earnings ratio 18.41, market capitalization USD 65.8 billion. Peer figures are dated October 22, 2026 at about 11:10 a.m. ET.

What the October 29 date means

The scheduled release gives investors the next fixed checkpoint for revenue, earnings and the fiscal 2026 outlook. The current price is 21.46 percent below the 52-week high, while the October 29 event is seven calendar days away from the October 22 quotation.

Price and reporting checkpoint

Stryker combines a scheduled October 29 results date with fiscal 2026 earnings per share guidance of USD 14.95-15.10. The stock's EUR 272.45 Lang & Schwarz price remains above the EUR 265.60 Xetra close used for the daily comparison.

The further course of trading is shown by the continuously updated real-time quote of Stryker stock.